Tag: oral molecule

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

• First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsOral molecule

Acceleware Ltd. Announces Closing of Shares for Debt Transactions

Providence St. Joseph Hospital Foundation Establishes First-Ever Endowed Chairs to Advance Excellence in Cardiac and Cancer Care

LungExpand Pro Gains 2025 Spotlight as Plant-Based Daily Support Formula Amid Rising Public Interest in Breathing Comfort and Respiratory Wellness

Tag: oral molecule

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us